Watchlist

Watchlist
Alder BioPharmaceuticals, Inc. (ALDR)
Alder BioPharmaceuticals, Inc. (ALDR)
Alder's (ALDR) CEO Randy Schatzman on Q3 2017 Results - Earnings Call Transcript
Alder BioPharmaceuticals (ALDR) Q3 2017 Results Earnings Conference Call November 7, 2017, 05:00 PM ET Executives David Walsey - VP, Corporate Communications Randy Schatzman - President and CEO Roger Cady - VP, Neurology Elisabeth Sandoval - CMO Larry Benedict - EVP and PAO …
Alder Bio beats by $0.29
Alder Bio (NASDAQ: ALDR ): Q3 EPS of -$0.92 beats by $0.29 . Press Release More news on: Alder Biopharmaceuticals Inc., Earnings news and commentary, Healthcare stocks news,
Notable earnings after Tuesday's close
AAOI , AAXN , ACAD , AFAM , AGTC , AGU , ALDR , ALEX , ALNY , AMED , APEI , APPS , ARNA , AXAS , BEAT , BETR , BUFF , CALX , CGBD , CHMI , CLI , CLR , COHR , CRZO , CSRA , CUTR , CVCO , CVG , CVNA , DAR , DCP , DEI , DEPO , DIOD , DOOR , DVA , EDIT , EL…
Your Daily Pharma Scoop: Celgene's Big Fall, Tesaro VARUBI Approval, TGTX Midstage Success
This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Celgene It has been a disas…
Canaccord bullish on Alder Bio, sees 82% upside; shares up 8%
Alder BioPharmaceuticals ( ALDR +7.5% ) is up on light volume on the heels of a bullish call from Canaccord Genuity (BUY/$20) based on prospects for migraine candidate eptinezumab. More news on: Alder Biopharmaceuticals Inc., Healthcare stocks news, Stocks on the move, Read more … ...
Your Daily Pharma Scoop: Gilead's Brave New World, AZN's Lynparza SNDA, RXDX Entrectinib Shows Positive Results
This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Gileads CART approval Today we…
Week 42 Breakout Forecast: Short-Term Picks To Give You An Edge
Week 42 Selections are as follows: Positive Acceleration Momentum Stocks This week I have selected 8 breakout stocks from the following sectors: 4 healthcare, 1 industrial goods, and 3 technology. I've included some background on stocks with interesting current news that may further …
Week 41 Breakout Forecast: Short-Term Picks To Give You An Edge
Week 41 Selections are as follows: Positive Acceleration Momentum Stocks This week I have selected 8 breakout stocks from the following sectors: 3 healthcare, 1 basic materials, 1 consumer goods and 3 technology. Charts for each stock are at the end of the article. The new sele…
Week 40 Breakout Forecast: Short-Term Picks To Give You An Edge
Week 40 Selections are as follows: Positive Acceleration Momentum Stocks This week I have selected 8 breakout stocks from the following sectors: 4 healthcare, 1 industrial goods, 1 basic materials, 1 services and 1 technology. Charts for each stock are at the end of the article. …
Premarket analyst action - healthcare
Agilent (NYSE: A ) resumed with Neutral rating and $68 (5% upside) price target by Goldman Sachs. More news on: Agilent Technologies Inc., Alder Biopharmaceuticals Inc., Illumina, Inc., Healthcare stocks news, Read more …
Short Sellers Are Wrong About Dish Network - Cramer's Lightning Round (9/18/17)
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Monday , September 18 . Bullish Calls U.S. Concrete (USCR): It's a wild trader but Cramer likes the stock. Alder Biopharmaceuticals (ALDR): They had setbacks but Cramer still believes in the stock. Dis…
Alder BioPharmaceuticals, Inc. (ALDR)